Cargando…

Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease

Improvements in living standards have led to non-alcoholic fatty liver disease (NAFLD), one of the most common chronic liver diseases worldwide. Recent studies have shown that N6-methyladenosine (m6A), a type of RNA modification, is strongly associated with many important biological processes. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yunchen, Zhang, Zhijian, Xiang, Liping, Zhou, Bing, Wang, Xuejiao, Lin, Yi, Ding, Xiaoying, Liu, Fang, Lu, Yan, Peng, Yongde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688819/ https://www.ncbi.nlm.nih.gov/pubmed/34950107 http://dx.doi.org/10.3389/fendo.2021.780617

Ejemplares similares

Regulatory Role of RNA N(6)-Methyladenosine Modification in Bone Biology and Osteoporosis
por: Chen, Xuejiao, et al.
Publicado: (2020)

Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota
por: Wang, Xuejiao, et al.
Publicado: (2022)

High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota
por: Wang, Xuejiao, et al.
Publicado: (2022)

N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism
por: Zhang, Haocheng, et al.
Publicado: (2023)

New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
por: Cheng, Wenli, et al.
Publicado: (2022)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
por: ter Horst, Kasper W., et al.
Publicado: (2017)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Modification of N(6)-methyladenosine RNA methylation on heat shock protein expression
por: Yu, Jiayao, et al.
Publicado: (2018)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish
por: Zou, Yun-Yi, et al.
Publicado: (2023)

Single-cell mapping of N6-methyladenosine in esophageal squamous cell carcinoma and exploration of the risk model for immune infiltration
por: Nie, Yuanliu, et al.
Publicado: (2023)

Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease
por: Skenderian, Shea, et al.
Publicado: (2020)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
por: Zhou, Zhijia, et al.
Publicado: (2022)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2022)

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology
por: Zhao, Jiahui, et al.
Publicado: (2023)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing
por: Huang, Xiaoyan, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
por: Arefhosseini, Sara, et al.
Publicado: (2022)

Association between hemoglobin glycation index and non-alcoholic fatty liver disease
por: Xing, Yuling, et al.
Publicado: (2023)

Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
por: Che, Wensheng, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
por: Memaj, Plator, et al.
Publicado: (2022)

Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes
por: Tan, Yijiong, et al.
Publicado: (2022)

Association of the Non‐Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross‐sectional study in China
por: Fan, Nengguang, et al.
Publicado: (2021)

Distinct impacts of fat and fructose on the liver, muscle, and adipose tissue metabolome: An integrated view
por: Meneses, Maria João, et al.
Publicado: (2022)

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
por: Sasaki, Akira, et al.
Publicado: (2014)

Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease
por: Furthner, Dieter, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population
por: Chen, Yi, et al.
Publicado: (2021)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

Erratum: Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
Publicado: (2023)

Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease
por: Liu, Linbo, et al.
Publicado: (2023)

Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease
por: Wu, Weiti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kh39oc77ifeggsosmkghn393np